Essential Oil Label Requirements: What Must Appear on the Bottle

Label non-compliance is the most common reason essential oil shipments get held at customs or pulled from marketplaces. The rules differ by market and by how the product is positioned (cosmetic, household, aromatherapy), so labeling belongs in the procurement spec, not the afterthought column.

The Universal Minimum

Across nearly every developed market, an essential oil label must show:

• Product identity (common name and, for single oils, the botanical name)
• Net quantity in metric and, for the US, US customary units
• Manufacturer, packer, or distributor name and address
• Country of origin
• Lot or batch code
• Hazard and precautionary statements where required
• Ingredient list in the correct nomenclature for the market

Everything else varies. Below is the market-by-market detail.

United States

The regulatory frame depends on intended use:

• Cosmetic (skin, hair): FDA under FD&C Act and Fair Packaging and Labeling Act. Ingredient list per INCI in descending order. Net quantity in both metric and US units (for example, “0.34 fl oz / 10 ml”). Distributor address with “manufactured for” or “distributed by” qualifier.
• Household / diffuser / room fragrance: Consumer Product Safety Commission under FHSA and PPPA. Signal word (DANGER, WARNING, or CAUTION), hazard statements, precautionary statements, and “Keep out of reach of children.” Child-resistant packaging may be required for oils containing methyl salicylate, certain camphor levels, or specific turpentine-derived components per 16 CFR 1700.14.
• Drug or therapeutic claim: FDA drug approval pathway. Avoid disease-treatment claims unless you have an NDA or OTC monograph compliance.

OSHA HazCom 2012 (GHS) labeling applies to workplace containers and B2B shipments, including a pictogram, signal word, and H/P statements on the outer carton.

European Union

Most retail essential oils sold for skin or aromatherapy land in the cosmetic frame under Regulation (EC) 1223/2009. Mandatory label content:

• Name and address of the Responsible Person
• Country of origin for imports
• Nominal content in ml or g
• Minimum durability (best before) or, above 30 months shelf life, a Period After Opening symbol (for example, 12M)
• Precautions of use
• Batch number
• Function of the product
• Ingredient list per INCI, in descending order, with the 26 listed fragrance allergens declared individually above 0.001% in leave-on or 0.01% in rinse-off

If positioned as a hazardous mixture (most citrus and conifer oils qualify), CLP Regulation 1272/2008 also applies: pictograms (often GHS02 flammable, GHS07 irritant, GHS08 sensitization, GHS09 environmental), signal word, H-statements, P-statements, and nominal quantity. Many EU essential oil labels carry both an INCI block and a CLP block.

United Kingdom

Post-Brexit, the UK mirrors the EU under UK Cosmetics Regulation and UK CLP, with two differences:

• The Responsible Person must be UK-established.
• Notifications go to the SCPN (Submit Cosmetic Product Notifications) portal, not CPNP.

Label content is otherwise identical to the EU.

Canada

Health Canada governs under the Consumer Chemicals and Containers Regulations and, for topical products, the Cosmetic Regulations under the Food and Drugs Act.

• Cosmetic: full INCI ingredient list per the Cosmetic Ingredient Hotlist, with bilingual (English and French) labeling mandatory.
• Hazardous consumer product: signal word, primary hazard statement, and precautionary statements bilingual, with the relevant hazard symbols.
• Net quantity in metric only.

Bilingual compliance is the most frequent failure point for US brands expanding into Canada.

Australia

Two regimes apply:

• Industrial / aromatherapy / diffuser: Australian Industrial Chemicals Introduction Scheme (AICIS) registration, plus GHS labeling under the model WHS Regulations.
• Therapeutic claim (sleep, anxiety, antifungal): TGA registration as a listed medicine (AUST L) with specific labeling rules including a black box with active ingredients.

Most aromatherapy oils sold without therapeutic claims run as industrial chemicals with GHS labels.

Practical Label Specifications

Once content is locked, specify the physical label:

• Material: BOPP or PE film with permanent acrylic adhesive. Paper labels fail in humid bathrooms and around oil drips.
• Adhesive rating: minimum service temperature -20 C to 80 C; oil-resistant topcoat.
• Print: 4-color process plus spot varnish or matte laminate; minimum 6 pt type for mandatory text, 8 pt preferred.
• Size: a 10 ml DIN 18 bottle takes roughly a 95 x 35 mm wrap label or a 50 x 70 mm front and 50 x 70 mm back panel.
• Variable data: batch code and best-before printed by thermal transfer or laser at fill, not pre-printed.

For CLP and FHSA labels, pictograms must meet minimum size rules (CLP: at least 1 cm square per pictogram on packages under 3 liters). Design the label grid around the pictograms first, then fit the marketing copy.

Common Failure Points

Auditors and marketplace reviewers most often flag:

1. Missing or incorrect allergen declarations (especially linalool, limonene, citral, geraniol)
2. Therapeutic claims on a cosmetic-labeled product (“cures insomnia,” “treats acne”)
3. Missing pictograms on citrus and conifer oils in the EU
4. English-only labels in Canada
5. Net quantity in fluid ounces only, no metric
6. No batch code, or batch code that does not match the COA
7. “100% pure” with no botanical name or origin

A Pre-Print Checklist

Before approving label artwork:

• Confirm regulatory frame per market (cosmetic, household, therapeutic)
• Verify INCI names against the current EU CosIng database
• Run allergen declarations against the latest formula at use level
• Have CLP / FHSA / GHS text reviewed by a regulatory consultant
• Check pictogram size, signal word, and statement order
• Confirm barcode (EAN-13 or UPC-A) scannability at print size
• Get a physical proof on the actual bottle, not just a PDF

A label that passes review in three markets is cheaper than three label revisions and a customs hold. Build the spec once, get it reviewed once, and reprint only when the formula or regulation changes.